BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 29512290)

  • 1. Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.
    Merola JF; Qureshi A; Husni ME
    Dermatol Ther; 2018 May; 31(3):e12589. PubMed ID: 29512290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles).
    Sánchez-Regaña M; Aldunce Soto MJ; Belinchón Romero I; Ribera Pibernat M; Lafuente-Urrez RF; Carrascosa Carrillo JM; Ferrándiz Foraster C; Puig Sanz L; Daudén Tello E; Vidal Sarró D; Ruiz-Villaverde R; Fonseca Capdevila E; Rodríguez Cerdeira MC; Alsina Gibert MM; Herrera Acosta E; Marrón Moya SE;
    Actas Dermosifiliogr; 2014 Dec; 105(10):923-34. PubMed ID: 24852726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.
    Handa S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):634-44. PubMed ID: 21079306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.
    Wozel G
    Clin Dermatol; 2008; 26(5):448-59. PubMed ID: 18755363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis.
    Iorizzo M
    Dermatol Clin; 2015 Apr; 33(2):175-83. PubMed ID: 25828710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmoplantar psoriasis.
    Engin B; Aşkın Ö; Tüzün Y
    Clin Dermatol; 2017; 35(1):19-27. PubMed ID: 27938808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis.
    Sarma N
    Indian J Dermatol; 2017; 62(2):113-122. PubMed ID: 28400628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problem sites: scalp, palm and sole, and nail.
    Larko O
    Dermatol Clin; 1995 Oct; 13(4):771-7. PubMed ID: 8785882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.
    Egeberg A; See K; Garrelts A; Burge R
    BMC Dermatol; 2020 May; 20(1):3. PubMed ID: 32434510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas.
    Kivelevitch D; Frieder J; Watson I; Paek SY; Menter MA
    Expert Opin Pharmacother; 2018 Apr; 19(6):561-575. PubMed ID: 29565192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.
    Foley P; Gordon K; Griffiths CEM; Wasfi Y; Randazzo B; Song M; Li S; Shen YK; Blauvelt A
    JAMA Dermatol; 2018 Jun; 154(6):676-683. PubMed ID: 29799960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral linear psoriasis with palmoplantar, nail, and scalp involvement.
    Saraswat A; Sandhu K; Shukla R; Handa S
    Pediatr Dermatol; 2004; 21(1):70-3. PubMed ID: 14871332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective efficacy and safety study of UVB-TL01 phototherapy and PUVA therapy in palmoplantar psoriasis].
    Redon E; Bursztejn AC; Loos C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2010 Oct; 137(10):597-603. PubMed ID: 20932438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital Psoriasis: Impact on Quality of Life and Treatment Options.
    Kelly A; Ryan C
    Am J Clin Dermatol; 2019 Oct; 20(5):639-646. PubMed ID: 31313079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails.
    Kragballe K
    Curr Probl Dermatol; 2009; 38():160-171. PubMed ID: 19710555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis in special localizations.
    Dopytalska K; Sobolewski P; Błaszczak A; Szymańska E; Walecka I
    Reumatologia; 2018; 56(6):392-398. PubMed ID: 30647487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis.
    Soni B; Shivgotra R; Trehan K; Chhina A; Saini M; Jain SK; Thakur S
    Curr Drug Targets; 2024; 25(5):353-373. PubMed ID: 38500274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study.
    Mastorino L; Burzi L; Frigatti G; Fazio A; Celoria V; Macagno N; Rosset F; Passerini SG; Roccuzzo G; Verrone A; Stroppiana E; Ortoncelli M; Dapavo P; Quaglino P; Ribero S
    Expert Opin Biol Ther; 2023; 23(9):929-936. PubMed ID: 37458181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalp psoriasis, clinical presentations and therapeutic management.
    van de Kerkhof PC; de Hoop D; de Korte J; Kuipers MV
    Dermatology; 1998; 197(4):326-34. PubMed ID: 9873169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of palmoplantar pustulosis: do we need to change?
    Mrowietz U; van de Kerkhof PC
    Br J Dermatol; 2011 May; 164(5):942-6. PubMed ID: 21275942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.